Jasper Therapeutics Inc. (NASDAQ:JSPR) reported a fourth-quarter loss of $0.32 per share for the period ending December 31, ...

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer, ...

ONCOMATRYX, a Spanish biopharmaceutical company developing Quantum ADCs against the tumor microenvironment, has successfully raised $67 million to foster the clinical development of novel candidates.

Lilly licenses Insilico's AI drug discovery platform in a deal worth up to $2.75B, signaling a shift in how novel ...

Centivax, Inc., a clinical-stage biotechnology company engineering vaccines and therapies for durable, universal protection ...

When patient safety, regulatory approval and real-world effectiveness are on the line, AI can't act autonomously.

Confirmed partial response at 220 mg indicates anti-tumor activity of APR-1051 in biomarker-defined cancersEarly clinical data suggest the ...

Bristol Myers Squibb has tapped up Faro to use AI to improve the Big Pharma's clinical trial protocols. | Bristol Myers ...

Dr. Conti joins Proxygen from Blueprint Medicines, where she identified four development candidates in seven years. Two of these were advanced to IND with unprecedented speed, while she ...

The partnership will combine Daiichi Sankyo’s clinical trial and preclinical research data with Tempus’ real-world data.

As clinical trials grow more complex, so does the volume of data that requires medical and operational review. Phase III trials now generate an average of 3.6 million data points—three times the ...

Intrinseque Health continues to set the benchmark for excellence by providing strategic and resilient clinical development supply chain solutions. Its unwavering commitment to quality, innovation, and ...